262 results on '"Broach, Vance"'
Search Results
2. ASO Visual Abstract: Oncologic and Perioperative Outcomes of Robot-Assisted Versus Conventional Laparoscopy for the Treatment of Clinically Uterine-Confined High-Grade Adenocarcinoma
3. ChatGPT compared to national guidelines for management of ovarian cancer: Did ChatGPT get it right? – A Memorial Sloan Kettering Cancer Center Team Ovary study
4. Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study
5. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group
6. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus
7. Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study
8. Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study
9. Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications
10. Laparoscopy with or without robotic assistance does not negatively impact long-term oncologic outcomes in patients with uterine serous carcinoma
11. Robotic Surgery in the Frail Elderly: Analysis of Perioperative Outcomes
12. Ovarian cancer mutational processes drive site-specific immune evasion
13. Contributors
14. Other rare vulvovaginal cancers: Verrucous carcinoma, aggressive angiomyxoma, vulvar yolk sac tumor
15. Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trial
16. Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon?
17. Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
18. A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration
19. Perioperative considerations for cancer patients with obesity: A narrative review
20. Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcoma
21. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort
22. Sentinel lymph node biopsy in patients with endometrial cancer and an indocyanine green or iodinated contrast reaction - A proposed management algorithm
23. ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer.
24. The impact of near-infrared angiography and proctoscopy after rectosigmoid resection and anastomosis performed during surgeries for gynecologic malignancies
25. Standardizing Opioid Prescriptions to Patients After Ambulatory Oncologic Surgery Reduces Overprescription
26. Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes
27. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy
28. Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma
29. Development and perception of surgery‐specific goals of care discussions in the preoperative setting: A learning pilot
30. Update on near infrared imaging technology: indocyanine green and near infrared technology in the treatment of gynecologic cancers
31. Secondary surgical resection for patients with recurrent uterine leiomyosarcoma
32. Gynecologic Survivorship Tool: Development, Implementation, and Symptom Outcomes
33. Supplementary Table S3 from Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
34. Supplementary Figure S3 from Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
35. Data from Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
36. PR034/#973 Oncologic outcomes of robot-assisted laparoscopy versus laparoscopy for the treatment of apparent early stage endometrioid adenocarcinoma of the uterus
37. Risk factors for financial toxicity in patients with gynecologic cancer
38. Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial
39. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group
40. #202 Near-infrared fluorescence assessment of myocutnaeous flap microperfusion for gynecologic reconstruction (FOREFRONT): a prospective, non-randomized trial (NCT05071976)
41. Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
42. Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism
43. Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcoma
44. IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers
45. Evolution and outcomes of sentinel lymph node mapping in vulvar cancer
46. FF006/#223 Radical cytoreductive surgery of the upper abdomen for advanced ovarian cancer
47. GSOR25 Presentation Time: 12:30 PM
48. Chapter 20 - Other rare vulvovaginal cancers: Verrucous carcinoma, aggressive angiomyxoma, vulvar yolk sac tumor
49. Chapter 18 - Bartholin gland carcinomas
50. Tumors of the Vulva and Vagina
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.